Your browser doesn't support javascript.
Author Correction: COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials.
Desai, Aakash; Gainor, Justin F; Hegde, Aparna; Schram, Alison M; Curigliano, Giuseppe; Pal, Sumanta; Liu, Stephen V; Halmos, Balazs; Groisberg, Roman; Grande, Enrique; Dragovich, Tomislav; Matrana, Marc; Agarwal, Neeraj; Chawla, Sant; Kato, Shumei; Morgan, Gilberto; Kasi, Pashtoon M; Solomon, Benjamin; Loong, Herbert H; Park, Haeseong; Choueiri, Toni K; Subbiah, Ishwaria M; Pemmaraju, Naveen; Subbiah, Vivek.
  • Desai A; Division of Medical Oncology, Mayo Clinic College of Medicine, Rochester, MN, USA.
  • Gainor JF; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Hegde A; Department of Hematology and Oncology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Schram AM; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Curigliano G; Department of Oncology and Hemato- Oncology, University of Milan and European Institute of Oncology, IRCCS, Milan, Italy.
  • Pal S; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Liu SV; Department of Developmental Therapeutics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
  • Halmos B; Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, The Bronx, NY, USA.
  • Groisberg R; Department of Melanoma/Sarcoma Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Grande E; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain.
  • Dragovich T; Department of Hematology/Oncology, MD Anderson Banner Cancer Center, Gilbert, AZ, USA.
  • Matrana M; Precision Cancer Therapies (Phase I) Research Program, Experimental Therapeutics, Ochsner, New Orleans, LA, USA.
  • Agarwal N; Division of Oncology, Department of Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Chawla S; Sarcoma Oncology Center, Santa Monia, CA, USA.
  • Kato S; Center for Personalized Cancer Therapy, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
  • Morgan G; Department of Oncology, Skåne University Hospital, Lund, Sweden.
  • Kasi PM; Division of Hematology, Oncology and Blood and Marrow Transplantation, Department of Medicine, University of Iowa, Iowa City, IA, USA.
  • Solomon B; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Loong HH; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Park H; Division of Oncology, Department of Medicine, Washington University in St. Louis, St Louis, MO, USA.
  • Choueiri TK; Department of Medical Oncology, Dana- Farber Cancer Institute, Boston, MA, USA.
  • Subbiah IM; Department of Palliative, Rehabilitation & Integrative Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pemmaraju N; Department of Leukemia, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Subbiah V; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. vsubbiah@mdanderson.org.
Nat Rev Clin Oncol ; 18(5): 320, 2021 May.
Article in English | MEDLINE | ID: covidwho-1157908
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Vaccines Language: English Journal: Nat Rev Clin Oncol Journal subject: Neoplasms Year: 2021 Document Type: Article Affiliation country: S41571-021-00503-2

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Vaccines Language: English Journal: Nat Rev Clin Oncol Journal subject: Neoplasms Year: 2021 Document Type: Article Affiliation country: S41571-021-00503-2